新冠肺炎时代对门诊患者的新要求:适应药学服务

LF Esther, Blessy Jose, D. Maria, J. Becerra, LS Beatriz, LG Natalia, S. Ramón, AV Amaya, S. Maite, NS Lorena
{"title":"新冠肺炎时代对门诊患者的新要求:适应药学服务","authors":"LF Esther, Blessy Jose, D. Maria, J. Becerra, LS Beatriz, LG Natalia, S. Ramón, AV Amaya, S. Maite, NS Lorena","doi":"10.1136/EJHPHARM-2021-EAHPCONF.30","DOIUrl":null,"url":null,"abstract":"Background and importanceAdapt the outpatients care activity to the scenario arising out of the COVID-19 pandemic Aim and objectivesReorganisation of the area, non in-person consultation, medication home delivery (MHD) and reduce patient attendance at day hospitals Material and methodsPhase 1 (P1): reinforcement of human resources, increase and easy the presential and telepharmacy schedule, adaptation of the facilities Phase 2 (P2): advanced preparation of the medication, MHD, substitution of intravenous treatments by subcutaneous treatments The telepharmacy and MHD were conducted at patients’ request Delivery routes and alternative urgent delivery systems were established P1 activities began 2 weeks prior to the announcement of the State of Alarm (SoA, 16 March 2020) and P2 began and continues for vulnerable patients Our project is currently underway in a proactive, selective and continuous way ResultsActivities were analysed during 2020, weeks 12–19 (16 March to 10 May 2020) and compared with theoretical activity during the same period in 2019, with an increase in activity (+21%) The difference between the sum of in-person and telematic consultations and the theoretical consultations for the period was named after omitted consultations Overall activity in weeks 12–19 was 5550 consultations, of which 4414 (79 5%) were in-person and 1136 (20 5%) telematic The estimated activity would have been 7030 consultations, and 1480 (21% of the theoretical ones) have been omitted In-person activity decreased from 5973 patients between weeks 12 and 19 in 2019 to 4414 in 2020 (−23 3%) Distribution of the 1136 MHD: week 12 (30), week 13 (131), week 14 (232), week 15 (190), week 16 (168), week 17 (155), week 18 (115) and week 19 (115) Waiting times for in-person consultation were reduced from an average of 5 2 min/patient in the pre-alarm period to 3 min during the alarm (−42 3%) Conclusion and relevanceOur data may be used to detect areas for improvement;consultations should be made proactively and tools are needed to qualitatively analyse omitted activity A system is needed to account for tele-assistance that has not resulted in dispensing medication or MHD References and/or acknowledgementsConflict of interestNo conflict of interest","PeriodicalId":11991,"journal":{"name":"European Journal of Hospital Pharmacy: Science and Practice","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2SPD-047 New requirements of outpatients in the COVID-19 era: adapting pharmaceutical care\",\"authors\":\"LF Esther, Blessy Jose, D. Maria, J. Becerra, LS Beatriz, LG Natalia, S. Ramón, AV Amaya, S. Maite, NS Lorena\",\"doi\":\"10.1136/EJHPHARM-2021-EAHPCONF.30\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background and importanceAdapt the outpatients care activity to the scenario arising out of the COVID-19 pandemic Aim and objectivesReorganisation of the area, non in-person consultation, medication home delivery (MHD) and reduce patient attendance at day hospitals Material and methodsPhase 1 (P1): reinforcement of human resources, increase and easy the presential and telepharmacy schedule, adaptation of the facilities Phase 2 (P2): advanced preparation of the medication, MHD, substitution of intravenous treatments by subcutaneous treatments The telepharmacy and MHD were conducted at patients’ request Delivery routes and alternative urgent delivery systems were established P1 activities began 2 weeks prior to the announcement of the State of Alarm (SoA, 16 March 2020) and P2 began and continues for vulnerable patients Our project is currently underway in a proactive, selective and continuous way ResultsActivities were analysed during 2020, weeks 12–19 (16 March to 10 May 2020) and compared with theoretical activity during the same period in 2019, with an increase in activity (+21%) The difference between the sum of in-person and telematic consultations and the theoretical consultations for the period was named after omitted consultations Overall activity in weeks 12–19 was 5550 consultations, of which 4414 (79 5%) were in-person and 1136 (20 5%) telematic The estimated activity would have been 7030 consultations, and 1480 (21% of the theoretical ones) have been omitted In-person activity decreased from 5973 patients between weeks 12 and 19 in 2019 to 4414 in 2020 (−23 3%) Distribution of the 1136 MHD: week 12 (30), week 13 (131), week 14 (232), week 15 (190), week 16 (168), week 17 (155), week 18 (115) and week 19 (115) Waiting times for in-person consultation were reduced from an average of 5 2 min/patient in the pre-alarm period to 3 min during the alarm (−42 3%) Conclusion and relevanceOur data may be used to detect areas for improvement;consultations should be made proactively and tools are needed to qualitatively analyse omitted activity A system is needed to account for tele-assistance that has not resulted in dispensing medication or MHD References and/or acknowledgementsConflict of interestNo conflict of interest\",\"PeriodicalId\":11991,\"journal\":{\"name\":\"European Journal of Hospital Pharmacy: Science and Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Hospital Pharmacy: Science and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.30\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Hospital Pharmacy: Science and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/EJHPHARM-2021-EAHPCONF.30","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景和重要性使门诊护理活动适应COVID-19大流行的情况目的和目标区域重组、非当面咨询、药物送货上门(MHD)和减少日间医院的病人出勤率材料和方法第一阶段(P1):加强人力资源,增加和简化现场和远程药房时间表,调整设施第二阶段(P2):提前准备药物、MHD、以皮下治疗替代静脉治疗远程药房和MHD应患者要求进行递送路线和替代性紧急递送系统建立了P1活动在宣布警报状态(SoA, 2020年3月16日)前两周开始,P2活动开始并继续针对弱势患者。结果分析了2020年12-19周(2020年3月16日至5月10日)的活动,并与2019年同期的理论活动进行了比较,活动增加了21%。该期间的现场和远程咨询与理论咨询的总和之间的差异以省略的咨询命名12-19周的总体活动为5550次咨询。其中4414例(79.5%)是面对面的,1136例(205%)是远程信息处理的。估计的活动是7030次咨询,1480例(21%的理论咨询)被忽略了。面对面的活动从2019年12至19周的5973例患者减少到2020年的4414例(- 23%)。12周(30),13周(131),14周(232),15周(190),16周(168),17周(155),18(115)和每周19(115)等待时间面对面协商减少从平均5 2分钟/病人在3分钟的预警时间报警(−42 3%)结论和relevanceOur数据可用于检测领域改进;磋商应主动和工具需要定性分析省略活动需要一个系统来占tele-assistance这并没有导致调剂药物或磁流体动力和/或引用利益冲突无利益冲突
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2SPD-047 New requirements of outpatients in the COVID-19 era: adapting pharmaceutical care
Background and importanceAdapt the outpatients care activity to the scenario arising out of the COVID-19 pandemic Aim and objectivesReorganisation of the area, non in-person consultation, medication home delivery (MHD) and reduce patient attendance at day hospitals Material and methodsPhase 1 (P1): reinforcement of human resources, increase and easy the presential and telepharmacy schedule, adaptation of the facilities Phase 2 (P2): advanced preparation of the medication, MHD, substitution of intravenous treatments by subcutaneous treatments The telepharmacy and MHD were conducted at patients’ request Delivery routes and alternative urgent delivery systems were established P1 activities began 2 weeks prior to the announcement of the State of Alarm (SoA, 16 March 2020) and P2 began and continues for vulnerable patients Our project is currently underway in a proactive, selective and continuous way ResultsActivities were analysed during 2020, weeks 12–19 (16 March to 10 May 2020) and compared with theoretical activity during the same period in 2019, with an increase in activity (+21%) The difference between the sum of in-person and telematic consultations and the theoretical consultations for the period was named after omitted consultations Overall activity in weeks 12–19 was 5550 consultations, of which 4414 (79 5%) were in-person and 1136 (20 5%) telematic The estimated activity would have been 7030 consultations, and 1480 (21% of the theoretical ones) have been omitted In-person activity decreased from 5973 patients between weeks 12 and 19 in 2019 to 4414 in 2020 (−23 3%) Distribution of the 1136 MHD: week 12 (30), week 13 (131), week 14 (232), week 15 (190), week 16 (168), week 17 (155), week 18 (115) and week 19 (115) Waiting times for in-person consultation were reduced from an average of 5 2 min/patient in the pre-alarm period to 3 min during the alarm (−42 3%) Conclusion and relevanceOur data may be used to detect areas for improvement;consultations should be made proactively and tools are needed to qualitatively analyse omitted activity A system is needed to account for tele-assistance that has not resulted in dispensing medication or MHD References and/or acknowledgementsConflict of interestNo conflict of interest
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Frequency of measuring body weight in (sub)populations of patients with cancer treated with chemotherapy. 4CPS-279 Cancer pain management approach considering potential drug interactions in patients receiving oral antitumour treatment 2SPD-048 Political report—options to break through medicine shortages 4CPS-239 Therapeutic drug monitoring of gentamicin in neonates 4CPS-390 Dispensing of anticancer investigational drugs during lockdown for the SARS-CoV-2 pandemic: experience in an oncological centre
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1